The Discounted Cash Flow (DCF) valuation of Cytosorbents Corp (CTSO) is (7.88) USD. With the latest stock price at 1.06 USD, the upside of Cytosorbents Corp based on DCF is -843.4%.
Based on the latest price of 1.06 USD and our DCF valuation, Cytosorbents Corp (CTSO) is a sell. selling CTSO stocks now will result in a potential gain of 843.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 7.9% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (32.60) - (4.64) | (7.88) |
| Upside | -3175.8% - -537.9% | -843.4% |